Best Medical Wearable Award to Biovotion
Best Medical Wearable award was presentedto Biovotion for its continuous, non-invasive physiological monitoring platform.
The Wearables Awards find and recognise those companies with the best – and most improved - product or service offering in the past 12 months,” said John Weir, COO, Evolve, organisers of the Wearable Technology Show.
“In addition to shining a light on the best products, they also reward the best wearable businesses, recognising those that have offered the highest level of innovation, performance and service over the past year.
The level of this year’s entrants was outstanding. It was a hard fought battle and our winners really are the crème de la crème of the wearables industry.
The Wearable Technology Show is the biggest of its kind with nearly 4’000 attendees, 108 companies exhibiting and numerous media professionals reporting from London this year..
Biovotion awarded CTI Label
Biovotion receives Swiss Commission for Technology and Innovation (CTI) quality label for entrepreneurial and technological excellence around its VSM platform. The Label is a seal of quality, a certificate of achievement, and a sign of credibility and readiness for sustainable growth.
After two years of coaching by the Swiss Commission for Technology and Innovation (CTI), Biovotion was awarded with the prestigious "CTI Start Up Label". To obtain the label, a company has to undergo several assessments that verify entrepreneurial excellence with substantial growth potential, a competent management team, market access, and a promising business model and product/technology.
CTI is Switzerland's innovation promotion agency. The Start-up Label is a seal of quality, a certificate of achievement, and a sign of credibility and readiness for sustainable growth. With this award the CTI acknowledges that Biovotion is professionally developed and has a sound basis for sustained future growth. As a condition for this award Biovotion successfully completed a formal due diligence, performed by external experts, on the practicability of Biovotion’s innovative wearable physiological multisensor monitoring technology, its intellectual property strategy, as well as the company’s business model and financials.
Biovotion President (USA)
Jonathan Cool has joined Biovotion, the company’s expansion operation into the North American market. Jonathan is a serial entrepreneur with more than 30 years of experience in the startup, operations and management of medical device, bio-pharmaceutical and health care delivery companies, including, Molecular Devices, Human Genome Sciences, CardioNet, and Cygnus Therapeutic Systems among others. He also was managing partner of Foundation Medical Partners – a health care venture capital fund affiliated with the Cleveland Clinic for many years. Jonathan joins Biovotion after more than a year of working closely with the management team in the development of an international expansion strategy. “We are very pleased to have Jonathan join our team to develop Biovotion’s foot print in the US. His expertise in the field as well as experience will greatly help the company, its partners and customers to continue pursue attractive business opportunities in North America”, says Andreas Caduff, CEO of Biovotion.
Biovotion & Infinity team up
Biovotion and Infinity, a Finnish Industrial Design firm team up to realise next generation physiological monitoring platform. Infinity holds extensive experience in wearable monitoring and medical devices and combines the two worlds in a remarkable way – optimal, to support Biovotion in the realisation of it’s completely cable free, minimalistic and robust next generation monitoring platform.
Biovotion & exceet team up
Biovotion & exceet/ECR team up to industrialize and manufacture Biovotion's Vital Sign Monitoring platform. exceet holds extensive experience in medical device engineering and manufacturing and offers a broad spectrum of identification, mobile security, localisation and embedded system solutions. Combined, making it a superb match to support the realisation of this next generation monitoring platform.